ArticleJournal of clinical immunology2013

MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1.

Zhuoan Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.